Acute Porphyria Drugs

Monograph

J01DB03 - Cefalotin
Propably not porphyrinogenic
PNP

Rationale
Cefalotin has no potentially porphyrinogenic pharmacokinetic or pharmacodynamic properties.
Chemical description
Beta-lactam antibiotic.
Therapeutic characteristics
Cefalotin is a semi synthetic first generation parental cephalosporin with a broad spectrum of antibiotic activity. It is used in the treatment of infections and for surgical infection prophylaxis.
Metabolism and pharmacokinetics
Cefalotin is partly metabolized to a less active desacetyl metabolite. 50-75% of the drug is eliminated unchanged in the urine. It has a half-life of 30-50 minutes. Not suspected to have any effect on the activities of cytochrome P450 enzymes.
Similar drugs
Explore alternative drugs in similar therapeutic classes J01D / J01DB or go back.
References
# Citation details PMID
*Drug reference publications
1. DrugBank. Cefalotin.
*Drug interaction databases
2. Lexicomp Online. Martindale: The Complete Drug Reference. Cefalotin Sodium. (27.07.2010)
*Summary of Product Characteristics
3. Norwegian medicines agency. Summary of Product Characteristics (SPC). Keflin.

Tradenames

Cefalotin Cefalotine Cefalotina Cefalotin
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙